Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NASDAQ:CDXS NASDAQ:GEVO NASDAQ:GPRE NYSE:WLKP On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeCDXSCodexis$2.57$2.57$0.96▼$3.87$233.61M2.48757,614 shs1.75 million shsGEVOGevo$1.54$1.75$1.12▼$2.97$374.85M0.993.22 million shs9.79 million shsGPREGreen Plains$14.82$15.89$5.37▼$18.94$1.04B1.191.47 million shs3.49 million shsWLKPWestlake Chemical Partners$22.66+0.2%$22.88$17.75▼$23.88$796.56M0.5224,809 shs31,210 shsDon't Wait for the OpenAI IPOThe AI wave will soon hit public markets with Anthropic and OpenAI set to go public later this year. However, you don't have to wait to invest. This report shows seven AI stocks that you can buy today while the big model providers get ready to go public.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceCDXSCodexis0.00%+7.08%-0.39%+60.63%+9.36%GEVOGevo0.00%+10.00%-6.10%-32.07%+11.59%GPREGreen Plains0.00%-1.20%-5.30%-4.39%+162.30%WLKPWestlake Chemical Partners0.00%-2.77%+1.25%+2.24%+2.70%Compare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeCDXSCodexis$2.57$2.57$0.96▼$3.87$233.61M2.48757,614 shs1.75 million shsGEVOGevo$1.54$1.75$1.12▼$2.97$374.85M0.993.22 million shs9.79 million shsGPREGreen Plains$14.82$15.89$5.37▼$18.94$1.04B1.191.47 million shs3.49 million shsWLKPWestlake Chemical Partners$22.66+0.2%$22.88$17.75▼$23.88$796.56M0.5224,809 shs31,210 shsDon't Wait for the OpenAI IPOThe AI wave will soon hit public markets with Anthropic and OpenAI set to go public later this year. However, you don't have to wait to invest. This report shows seven AI stocks that you can buy today while the big model providers get ready to go public.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceCDXSCodexis0.00%+7.08%-0.39%+60.63%+9.36%GEVOGevo0.00%+10.00%-6.10%-32.07%+11.59%GPREGreen Plains0.00%-1.20%-5.30%-4.39%+162.30%WLKPWestlake Chemical Partners0.00%-2.77%+1.25%+2.24%+2.70%Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceCDXSCodexis 2.00Hold$5.0094.55% UpsideGEVOGevo 2.00Hold$2.7578.57% UpsideGPREGreen Plains 2.33Hold$14.29-3.61% DownsideWLKPWestlake Chemical Partners 2.50Moderate BuyN/AN/ACurrent Analyst Ratings BreakdownLatest CDXS, GEVO, GPRE, and WLKP Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails6/17/2026CDXSCodexis Cantor FitzgeraldSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingOverweight5/26/2026GEVOGevo HC WainwrightSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingBuy5/22/2026CDXSCodexis Weiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingDowngradeSell (D-) ➝ Sell (E+)5/22/2026GEVOGevo UBS GroupSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingNeutral$2.25 ➝ $2.005/21/2026WLKPWestlake Chemical Partners Weiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingUpgradeHold (C) ➝ Buy (B-)5/12/2026GPREGreen Plains Zacks ResearchSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingUpgradeHold ➝ Strong-Buy5/8/2026CDXSCodexis Weiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingUpgradeSell (E+) ➝ Sell (D-)5/8/2026GPREGreen Plains OppenheimerSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingOutperform$20.005/8/2026GEVOGevo Zacks ResearchSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingDowngradeHold ➝ Strong Sell5/8/2026GPREGreen Plains StephensSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingBoost Price TargetOverweight$18.00 ➝ $20.005/7/2026WLKPWestlake Chemical Partners Weiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingDowngradeHold (C+) ➝ Hold (C)(Data available from 6/20/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookCDXSCodexis$70.39M3.32N/AN/A$0.56 per share4.59GEVOGevo$160.58M2.33N/AN/A$1.92 per share0.80GPREGreen Plains$2.09B0.50$0.59 per share25.17$11.05 per share1.34WLKPWestlake Chemical Partners$1.17B0.68$5.02 per share4.51$22.76 per share1.00Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateCDXSCodexis-$43.97M-$0.37N/AN/AN/A-40.97%-68.09%-23.72%8/12/2026 (Estimated)GEVOGevo-$33.84M-$0.13N/AN/AN/A-19.38%-5.06%-3.41%8/10/2026 (Estimated)GPREGreen Plains-$121.28M-$0.33N/A8.10N/A-0.80%2.86%1.39%8/10/2026 (Estimated)WLKPWestlake Chemical Partners$48.70M$1.6413.8113.250.644.69%7.15%4.57%8/4/2026 (Estimated)Latest CDXS, GEVO, GPRE, and WLKP EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails5/7/2026Q1 2026CDXSCodexis-$0.11-$0.10+$0.01-$0.10$14.53 million$15.25 million5/7/2026Q1 2026GEVOGevo-$0.02-$0.05-$0.03-$0.09$44.90 million$42.95 million5/7/2026Q1 2026GPREGreen Plains-$0.01$0.42+$0.43$0.42$532.53 million$445.80 million5/5/2026Q1 2026WLKPWestlake Chemical Partners$0.43$0.40-$0.03$0.40$522.00 million$305.68 millionCompare DividendsCompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive GrowthCDXSCodexisN/AN/AN/AN/AN/AGEVOGevoN/AN/AN/AN/AN/AGPREGreen PlainsN/AN/AN/AN/AN/AWLKPWestlake Chemical Partners$1.898.34%N/A115.24%N/ALatest CDXS, GEVO, GPRE, and WLKP DividendsAnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date5/4/2026WLKPWestlake Chemical Partnersquarterly$0.47148.17%5/14/20265/14/20266/1/2026(Data available from 1/1/2013 forward)Compare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioCDXSCodexis0.945.365.23GEVOGevo0.374.313.51GPREGreen Plains0.491.711.27WLKPWestlake Chemical Partners0.503.653.57Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipCDXSCodexis78.54%GEVOGevo35.17%GPREGreen PlainsN/AWLKPWestlake Chemical Partners78.28%Insider OwnershipCompanyInsider OwnershipCDXSCodexis3.50%GEVOGevo7.09%GPREGreen Plains1.40%WLKPWestlake Chemical Partners1.10%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableCDXSCodexis25090.90 million87.72 millionOptionableGEVOGevo100243.41 million226.15 millionOptionableGPREGreen Plains90070.03 million69.05 millionOptionableWLKPWestlake Chemical Partners15035.25 million34.86 millionOptionableCDXS, GEVO, GPRE, and WLKP HeadlinesRecent News About These CompaniesWestlake Chemical Partners: Stock Is Range BoundJune 9, 2026 | seekingalpha.comWestlake Chemical Partners LP Common Units (WLKP) Q1 2026 Earnings Call TranscriptMay 5, 2026 | seekingalpha.comWestlake Chemical (WLKP) Q1 2026 Earnings TranscriptMay 5, 2026 | fool.comWestlake Chemical Partners LP Announces First Quarter 2026 ResultsMay 5, 2026 | businesswire.comWestlake Chemical Partners Q1 2026 earnings previewMay 4, 2026 | msn.comWestlake Chemical Partners LP Announces First Quarter 2026 DistributionMay 4, 2026 | finance.yahoo.comWhat To Expect From Westlake Chemical Partners LP (WLKP) Q1 2026 EarningsMay 4, 2026 | finance.yahoo.comWestlake Chemical Partners Announce First Quarter 2026 Conference CallApril 21, 2026 | finance.yahoo.comWestlake Chemical Partners LP names new CFOApril 20, 2026 | msn.comWestlake Chemical Partners Appoints Jonathan H. Baksht as Senior Vice President and Chief Financial OfficerApril 20, 2026 | businesswire.comWestlake Chemical Partners LP Filed Annual ReportMarch 4, 2026 | businesswire.comWestlake Chemical Partners LP (WLKP) Q4 2025 Earnings Call Highlights: Navigating Challenges ...February 24, 2026 | finance.yahoo.comWestlake Chemical Partners beats Q4 earnings expectationsFebruary 24, 2026 | za.investing.comWestlake Chemical Partners beats Q4 profit forecasts despite revenue missFebruary 24, 2026 | msn.comWestlake Chemical Partners signals distributable cash flow recovery in 2026 with no planned turnaroundsFebruary 24, 2026 | msn.comWestlake Chemical Partners LP Common Units (WLKP) Q4 2025 Earnings Call TranscriptFebruary 24, 2026 | seekingalpha.comWLKP Reports EarningsFebruary 24, 2026 | fool.comWestlake Chemical Partners LP Announces Fourth Quarter and Full Year 2025 ResultsFebruary 24, 2026 | businesswire.comWestlake Chemical Partners LP (WLKP) Q4 2025 Earnings Report Preview: What To ExpectFebruary 23, 2026 | finance.yahoo.comWestlake Chemical Partners LP - Deep Value In The Chemical Infrastructure SectorFebruary 6, 2026 | talkmarkets.comNew MarketBeat Followers Over TimeMedia Sentiment Over TimeCDXS, GEVO, GPRE, and WLKP Company DescriptionsCodexis NASDAQ:CDXS$2.57 0.00 (0.00%) As of 06/18/2026 04:00 PM EasternCodexis, Inc. discovers, develops, and sells enzymes and other proteins. The company operates through two segments, Performance Enzymes and Novel Biotherapeutics. It offers biocatalyst products and services. The company also provides biocatalyst screening and protein engineering services. In addition, it offers CodeEvolver, a technology platform, which helps in developing and delivering biocatalysts that perform chemical transformations and enhance the efficiency and productivity of manufacturing processes. The company's platform is also used for molecular biology and in vitro diagnostic enzymes. It has a collaboration agreement with Nestlé Health Science to develop CDX-7108 for the treatment of exocrine pancreatic insufficiency. The company sells its products to pharmaceutical manufacturers through its direct sales and business development force in the United States and Europe. The company was incorporated in 2002 and is headquartered in Redwood City, California.Gevo NASDAQ:GEVO$1.54 0.00 (0.00%) Closing price 06/18/2026 04:00 PM EasternExtended Trading$1.52 -0.02 (-1.30%) As of 06/18/2026 07:57 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.Gevo, Inc. operates as a carbon abatement company. It operates through three segments: Gevo, Agri-Energy, and Renewable Natural Gas. The company focuses on transforming renewable energy into energy-dense liquid hydrocarbons that can be used as renewable fuels. It offers renewable gasoline and diesel, isobutanol, sustainable aviation fuel, renewable natural gas, isobutylene, ethanol, and animal feed and protein. The company was formerly known as Methanotech, Inc. and changed its name to Gevo, Inc. in March 2006. Gevo, Inc. was incorporated in 2005 and is headquartered in Englewood, Colorado.Green Plains NASDAQ:GPRE$14.82 0.00 (0.00%) Closing price 06/18/2026 04:00 PM EasternExtended Trading$14.91 +0.09 (+0.61%) As of 06/18/2026 07:40 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.Green Plains Inc. produces low-carbon fuels in the United States and internationally. It operates through three segments: Ethanol Production, Agribusiness and Energy Services, and Partnership. The Ethanol Production segment produces ethanol, distillers grains, and ultra-high protein and renewable corn oil. The Agribusiness and Energy Services segment engages in the grain procurement, handling and storage, commodity marketing business; and trading of ethanol, distiller grains, renewable corn oil, grain, natural gas, and other commodities in various markets. This segment also provides grain drying and storage services to grain producers. The Partnership segment offers fuel storage and transportation services. It operates 24 ethanol storage facilities; two fuel terminal facilities; and a fleet of approximately 2,180 leased railcars. The company was formerly known as Green Plains Renewable Energy, Inc. and changed its name to Green Plains Inc. in May 2014. Green Plains Inc. was incorporated in 2004 and is headquartered in Omaha, Nebraska.Westlake Chemical Partners NYSE:WLKP$22.66 +0.06 (+0.24%) Closing price 06/18/2026 03:58 PM EasternExtended Trading$22.65 -0.01 (-0.02%) As of 06/18/2026 04:10 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.Westlake Chemical Partners LP acquires, develops, and operates ethylene production facilities and related assets in the United States. The company's ethylene production facilities primarily convert ethane into ethylene. It also sells ethylene co-products, such as propylene, crude butadiene, pyrolysis gasoline, and hydrogen directly to third parties on either a spot or contract basis. Westlake Chemical Partners GP LLC serves as the general partner of the company. Westlake Chemical Partners LP was founded in 1991 and is headquartered in Houston, Texas. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30DroneEcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerFlying CarGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMade In AmericaMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSilverSocial MediaSolarSpaceTechnologyTelecomToyUraniumUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas MarketBeat Week in Review – 06/15 - 06/19 Satellogic Is Tiny But Its Revenue Growth Is Hard to Ignore Aehr Spikes on New Order, But Has Stock Gotten Ahead of Itself? Why Kroger’s Pullback Could Be a Gift for Patient Investors Credo Technologies Accelerates AI—Its Stock Price Will Follow Why Rocket Lab’s Nasdaq-100 Moment Could Change the Story Why Palantir’s Google Cloud Deal Could Change the Debate VMware: Broadcom's Second Biggest Business Set to Accelerate Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
